Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
Download App
简
繁
简
繁
EN
Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
HOME
·
AIM VACCINE
AIM VACCINE(06660.HK)2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 122.82 million, loss narrowed by 6.33% YoY
Tags:
AIM VACCINE
06660.HK
NewTimeSpace
2026-08-24
AIM Vaccine (06660.HK): Marketing Application Submitted for High-Potency Human Diploid Rabies Vaccine with Optimized Manufacturing Process
Tags:
AIM VACCINE
06660.HK
2026-08-24
AIM Vaccine (06660.HK): Serum-Free Iterative Rabies Vaccine Completes Supplementary Data Submission for Registration; NDA Achieves Key Milestone
Tags:
AIM VACCINE
06660.HK
2026-08-03
AIM VACCINE(06660.HK) closed 21.83% higher, the latest market capitalization at HKD 1.56 billion
Tags:
AIM VACCINE
06660.HK
2026-05-08
Finance
WUXI APPTEC (02359.HK): US DoD Removes It from 1260H List
Finance
IMPACT THERAP-B (07630.HK): EU Approves Senaparib for Ovarian Cancer
Finance
BANKOFZHENGZHOU (06196.HK): Redeems RMB10bn Perpetual Capital Bonds
Research
HK Stock Connect Daily Report: AKESO -22.11% after FDA CRL - 20261116
Research
Hong Kong Recently Listed Stocks Daily Report: METALIGHT Rises 32.27% to Lead, Computing Power Chip Theme Heats Up-20261116
Research
HK AI Concept Stock Daily: MINIMAX-W -18.04%; UBTECH JV Deal 20261116
Finance
SIHUAN PHARM (00460.HK): bireociclib indication added to national NRDL
Finance
51WORLD (06651.HK): kicks off Shenzhen A-share IPO with adviser
Finance
YANGTZEKIANG (00294.HK): interim loss seen down to HKD 13 million
Research
Offshore Trust Insight | LUK FOOK HOLD (00590.HK) Reports FY2025/26 Revenue of HKD 17.205 Billion; Founder Trust Holds About 40.65%
Scan QR Code
Download App